Clinical Trials

Showing trials with last updates posted in 2026.

NCT07098936 | RECRUITING | PHASE2
57 participants

Momelotinib in VEXAS Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2025-11-25
Completion:
2028-06-30
Conditions
  • VEXAS Syndome
  • Myelo Dysplastic Syndrome
Interventions
  • DRUG
No Results Yet
NCT07090135 | RECRUITING | NA
25 participants

Power Nap With TES-TI

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2025-12-19
Completion:
2026-09-30
Conditions
  • Non-restorative Sleep
  • Healthy Volunteer
Interventions
  • DEVICE
No Results Yet
NCT07049861 | RECRUITING | NA
6200 participants

Advancing Biopsychosocial Care Training Initiative

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2025-07-14
Completion:
2028-12-15
Conditions
  • Weight Management
  • Obesity Prevention
  • Obesity and Obesity-related Medical Conditions
  • Obesity and Overweight
  • Obesity
Interventions
  • OTHER
No Results Yet
NCT07044310 | RECRUITING | PHASE2
38 participants

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2025-07-25
Completion:
2027-07-25
Conditions
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
No Results Yet
NCT06951906 | RECRUITING | PHASE4
54 participants

Imaging Biomarkers of FOG Response to DBS

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2024-11-11
Completion:
2029-11-30
Conditions
  • Freezing of Gait Symptoms in Parkinson's Disease
  • Deep Brain Stimulation
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT06920771 | COMPLETED | PHASE3
691 participants

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2024-09-09
Completion:
2026-03-30
Conditions
  • House Dust Mite Allergy
  • House Dust Mite Rhinitis
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page